ViiV Healthcare has announced that its long-acting HIV pre-exposure prophylaxis (PrEP) therapy, cabotegravir, demonstrated superior acceptability among patients compared to Gilead Sciences‘ lenacapavir in an early-stage...
As the respiratory illness season approaches, British Columbia is set to begin its annual vaccination campaign for both COVID-19 and influenza. Notifications for vaccine appointments started...
Interest in pharmaceutical companies continues to grow as investors seek attractive opportunities in a fluctuating market. Recently, analysts from Seeking Alpha, specifically from The Value Portfolio...
Pfizer’s shares experienced a notable increase on Tuesday morning following a report by The Washington Post indicating that President Donald Trump is poised to announce an...
Pfizer is nearing an agreement for a significant acquisition of the weight-loss drugmaker Metsera, valued at approximately $7.3 billion. According to a report by the Financial...
